590782388 | vmc | 87702030 | | 7331709 | 4/7/2006 12:00:00 am | urinary tract infection | signed | dis | admission date: 6/17/2006 report status: signeddischarge date: 4/17/2006attending: simmon , jeffery mdaddendum:addendum to discharge summary , record number #8830141 which wasdictated by kovats , doyle bradly .addendum to discharge summary:neuro: neurology consult was obtained for increased somnolenceover the past three weeks , which was noted per the patient's sonwhich he thinks is a change from baseline. neurology consultrecommended that we get an mri/mra of the brain with gadoliniumcontrast to look for leptomeningeal disease and other sources forincreased somnolence which are treatable. they also recommendedan eeg be done. the eeg was done and showed no seizure activity.the mri/mra was done and showed only a right mca infarct , whichwas known and old with no interval change. gadolinium contrastwas not given because the patient became too agitated and wasmoving too much during the study for an effective study to beobtained. they also recommended that we check certain labsincluding folate , b12 , tsh and rpr all of which were essentiallynormal. tsh was elevated but patient has a history ofhypothyroidism and is on synthroid. neurology was consulted onthe day of discharge and they agreed that no further evaluationof the somnolence is necessary at this time. if the somnolencecontinues into the near future further evaluation may benecessary. leptomeningeal disease is unlikely given the lack ofnew neurological findings , and since the patient is scheduled fora pet scan of the chest to evaluate for spread of her known lungcancer , if there is no interval change in her oncological processthe likeliness of leptomeningeal disease is quite low.discharge medications: enteric-coated aspirin 81 mg p.o. daily ,vitamin b12 1000 mcg p.o. daily , colace 100 mg p.o. b.i.d. ,synthroid 100 mcg p.o. daily , niferex-150 150 mg p.o. b.i.d. ,senna two tablets p.o. b.i.d. , zocor 20 mg p.o. nightly ,neurontin 100 mg p.o. b.i.d. , lovenox 40 mg subcu daily , lamictal200 mg p.o. b.i.d. , seroquel 100 mg p.o. b.i.d. , nexium 20 mgp.o. daily , lidoderm 5% patch topically daily , novolog slidingscale , cymbalta 20 mg p.o. b.i.d. , toprol-xl 100 mg p.o. daily.discharge exam: on the day of discharge , the patient wasafebrile with a temperature of 96.7. she remained slightlyhypertensive with a blood pressure range of 103 to 152 systolicand 54 to 90 diastolic. her heart rate , respirations and oxygensaturations were all normal. she was urinating on her ownwithout a foley catheter. her blood sugars were stable. aone-to-one sitter which had been placed prior during her hospitalcourse was discontinued. her ciprofloxacin course for herurinary tract infection was discontinued because she had beentreated fully and her lopressor was changed to toprol-xl theextended release formulation for improved compliance andconvenience. at discharge , ms. klein 's mental statusremained at baseline and she showed no signs of agitation at thetime of my exam.follow-up appointments: she has an appointment with her primarycare physician dr. baney , phone number is 010-743-1248 on10/26/06 at 10:40 a.m. she also has an appointment withneurology dr. duplaga , phone number is 891-850-7392 and that ison 11/18/06 at 12:30 p.m. she has a pet study of her chest ,which has been scheduled on 8/21/06 at 08:30 a.m.patient's oncologist: rusty magnall , md at purcmount catstic hospital cancerinstitute , phone number 763-624-6925. his e-mail address isgdupxqa xlmfl@ rprr. ttdtfdm.uqw.escription document: 3-8248157 cssten telcc: darryl mak m.d.man ponce alecc: weldon polakoff mdport , welldictated by: grillette , stephanattending: mad , elijahdictation id 2896395d: 3/10/06t: 3/10/06